Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition - PubMed (original) (raw)
. 2014 Apr 1;127(Pt 7):1523-36.
doi: 10.1242/jcs.139865. Epub 2014 Feb 19.
Affiliations
- PMID: 24554433
- DOI: 10.1242/jcs.139865
Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition
Maren Diepenbruck et al. J Cell Sci. 2014.
Abstract
The cellular changes during an epithelial-mesenchymal transition (EMT) largely rely on global changes in gene expression orchestrated by transcription factors. Tead transcription factors and their transcriptional co-activators Yap and Taz have been previously implicated in promoting an EMT; however, their direct transcriptional target genes and their functional role during EMT have remained elusive. We have uncovered a previously unanticipated role of the transcription factor Tead2 during EMT. During EMT in mammary gland epithelial cells and breast cancer cells, levels of Tead2 increase in the nucleus of cells, thereby directing a predominant nuclear localization of its co-factors Yap and Taz via the formation of Tead2-Yap-Taz complexes. Genome-wide chromatin immunoprecipitation and next generation sequencing in combination with gene expression profiling revealed the transcriptional targets of Tead2 during EMT. Among these, zyxin contributes to the migratory and invasive phenotype evoked by Tead2. The results demonstrate that Tead transcription factors are crucial regulators of the cellular distribution of Yap and Taz, and together they control the expression of genes critical for EMT and metastasis.
Keywords: Breast cancer; EMT; Taz; Tead; Yap; Zyxin; metastasis.
Similar articles
- YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner.
Han D, Byun SH, Park S, Kim J, Kim I, Ha S, Kwon M, Yoon K. Han D, et al. Biochem Biophys Res Commun. 2015 Feb 27;458(1):110-6. doi: 10.1016/j.bbrc.2015.01.077. Epub 2015 Jan 26. Biochem Biophys Res Commun. 2015. PMID: 25634692 - Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
Akrida I, Makrygianni M, Nikou S, Mulita F, Bravou V, Papadaki H. Akrida I, et al. Pathol Res Pract. 2024 Oct;262:155551. doi: 10.1016/j.prp.2024.155551. Epub 2024 Aug 15. Pathol Res Pract. 2024. PMID: 39153238 - Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D, Zhu GY, Lu Y, Yang A, Chen D, Huang HJ, Peng SX, Chen LW, Li YW. Cao D, et al. Biomed Pharmacother. 2020 Sep;129:110462. doi: 10.1016/j.biopha.2020.110462. Epub 2020 Jul 6. Biomed Pharmacother. 2020. PMID: 32768952 - A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.
Pobbati AV, Hong W. Pobbati AV, et al. Theranostics. 2020 Feb 18;10(8):3622-3635. doi: 10.7150/thno.40889. eCollection 2020. Theranostics. 2020. PMID: 32206112 Free PMC article. Review. - The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.
Maugeri-Saccà M, Barba M, Pizzuti L, Vici P, Di Lauro L, Dattilo R, Vitale I, Bartucci M, Mottolese M, De Maria R. Maugeri-Saccà M, et al. Expert Rev Mol Med. 2015 Jul 2;17:e14. doi: 10.1017/erm.2015.12. Expert Rev Mol Med. 2015. PMID: 26136233 Review.
Cited by
- TEADs serve as potential prognostic biomarkers and targets for human gastric cancer.
Wang MH, Li BZ, Chen Y, Wang J. Wang MH, et al. BMC Gastroenterol. 2022 Jun 24;22(1):308. doi: 10.1186/s12876-022-02386-8. BMC Gastroenterol. 2022. PMID: 35739490 Free PMC article. - Nutrient-Dependent Changes of Protein Palmitoylation: Impact on Nuclear Enzymes and Regulation of Gene Expression.
Spinelli M, Fusco S, Grassi C. Spinelli M, et al. Int J Mol Sci. 2018 Nov 30;19(12):3820. doi: 10.3390/ijms19123820. Int J Mol Sci. 2018. PMID: 30513609 Free PMC article. Review. - Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching.
Lüönd F, Pirkl M, Hisano M, Prestigiacomo V, Kalathur RK, Beerenwinkel N, Christofori G. Lüönd F, et al. Life Sci Alliance. 2021 Nov 24;5(2):e202101010. doi: 10.26508/lsa.202101010. Print 2022 Feb. Life Sci Alliance. 2021. PMID: 34819356 Free PMC article. - Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
Morice S, Danieau G, Rédini F, Brounais-Le-Royer B, Verrecchia F. Morice S, et al. Cancers (Basel). 2020 Mar 10;12(3):645. doi: 10.3390/cancers12030645. Cancers (Basel). 2020. PMID: 32164350 Free PMC article. Review. - Regulation of TEAD Transcription Factors in Cancer Biology.
Huh HD, Kim DH, Jeong HS, Park HW. Huh HD, et al. Cells. 2019 Jun 17;8(6):600. doi: 10.3390/cells8060600. Cells. 2019. PMID: 31212916 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases